Lithuania vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB
Lithuania
100.0%
in 2024
Zimbabwe
100.0%
in 2024
Lithuania rank
1st
Zimbabwe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Lithuania
- Zimbabwe
How they compare
Lithuania currently reports 100.0% against 100.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2011 it was Lithuania ahead.
Lithuania ranks 1st and Zimbabwe ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 34.7% | 65.3% | Lithuania |
| 2020s | 100.0% | 98.0% | 2.0% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Lithuania or Zimbabwe?
- Lithuania, at 100.0% against 100.0% in Zimbabwe as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Lithuania and Zimbabwe?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Zimbabwe?
- 9 years are reported by both, from 2011 to 2024.
- How do Lithuania and Zimbabwe rank globally for previously treated cases tested for rr-/mdr-tb?
- Lithuania ranks 1st and Zimbabwe ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.